Key findings revealed that BC significantly reduced PD-L1 levels in CRC cells by inhibiting its palmitoylation via DHHC3, preventing PD-L1 recycling to the cell membrane and redirecting it to lysosomal degradation. The gene discussed is ZDHHC3; the disease is breast cancer.